Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Lenaz

Showing results (31-40 of 46) with videos related to

Pageof 5
Sort By:
Cancer Treatment Reviews|December 1, 1988
Chemotherapy of gastric cancerP Preusser, W Achterrath, H Wilke, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1992
Carboplatin: an active drug in metastatic breast cancerM Martín, E Díaz-Rubio, A Casado, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1989
Phase II study with the combination etoposide, doxorubicin, and cisplatin in advanced measurable gastric cancerP Preusser, H Wilke, W Achterrath, et al.
European Journal of Cancer|December 1, 1980
Carminomycin (NSC-180024): a phase I studyR Abele, M Rozencweig, J J Body, et al.
Drug Development and Industrial Pharmacy|July 30, 2008
Complexation study of the anticancer agent EO-9 with 2-hydroxypropyl-beta-cyclodextrinJ H Beijnen, S C van der Schoot, B Nuijen, et al.
Seminars in Oncology|October 1, 1994
Carboplatin and radiotherapy in the treatment of head and neck cancer: six years' experienceN Zamboglou, T Schnabel, C Kolotas, et al.
International Journal of Pharmaceutics|October 3, 2006
EO-9 bladder instillations: formulation selection based on stability characteristics and in vitro simulation studiesS C van der Schoot, L D Vainchtein, J H Beijnen, et al.
Die Pharmazie|December 17, 2008
Purity profile of the indoloquinone anticancer agent EO-9 and chemical stability of EO-9 freeze dried with 2-hydroxypropyl-beta-cyclodextrinS C van der Schoot, L D Vainchtein, B Nuijen, et al.
European Journal of Cancer & Clinical Oncology|April 1, 1983
Clinical phase I trial of marcellomycin with a single-dose scheduleC Nicaise, M Rozencweig, M de Marneffe, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 30, 1998
Paclitaxel in combination with weekly 24-hour infusional 5-fluorouracil plus leucovorin in the second-line treatment of metastatic breast cancer: results of a phase II studyU Klaassen, H Wilke, A Harstrick, et al.
Pageof 5

Showing results (31-40 of 46) with videos related to

Sort By:
Pageof 5
Cancer Treatment Reviews|December 1, 1988
Chemotherapy of gastric cancerP Preusser, W Achterrath, H Wilke, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1992
Carboplatin: an active drug in metastatic breast cancerM Martín, E Díaz-Rubio, A Casado, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1989
Phase II study with the combination etoposide, doxorubicin, and cisplatin in advanced measurable gastric cancerP Preusser, H Wilke, W Achterrath, et al.
European Journal of Cancer|December 1, 1980
Carminomycin (NSC-180024): a phase I studyR Abele, M Rozencweig, J J Body, et al.
Drug Development and Industrial Pharmacy|July 30, 2008
Complexation study of the anticancer agent EO-9 with 2-hydroxypropyl-beta-cyclodextrinJ H Beijnen, S C van der Schoot, B Nuijen, et al.
Seminars in Oncology|October 1, 1994
Carboplatin and radiotherapy in the treatment of head and neck cancer: six years' experienceN Zamboglou, T Schnabel, C Kolotas, et al.
International Journal of Pharmaceutics|October 3, 2006
EO-9 bladder instillations: formulation selection based on stability characteristics and in vitro simulation studiesS C van der Schoot, L D Vainchtein, J H Beijnen, et al.
Die Pharmazie|December 17, 2008
Purity profile of the indoloquinone anticancer agent EO-9 and chemical stability of EO-9 freeze dried with 2-hydroxypropyl-beta-cyclodextrinS C van der Schoot, L D Vainchtein, B Nuijen, et al.
European Journal of Cancer & Clinical Oncology|April 1, 1983
Clinical phase I trial of marcellomycin with a single-dose scheduleC Nicaise, M Rozencweig, M de Marneffe, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 30, 1998
Paclitaxel in combination with weekly 24-hour infusional 5-fluorouracil plus leucovorin in the second-line treatment of metastatic breast cancer: results of a phase II studyU Klaassen, H Wilke, A Harstrick, et al.
Pageof 5